APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.

Saved in:
Bibliographic Details
Main Authors Sullivan, Gerard M, Wang, Le, Bruncko, Milan, Ding, Hong, Elmore, Steven W, Kunzer, Aaron R, Hasvold, Lisa A, Wang, Xilu, Tao, Zhi-Fu, Hexamer, Laura, Song, Xiaohong, Wendt, Michael D, Wang, Gary T, Hansen, Todd M, Doherty, George A, Souers, Andrew J, Mantei, Robert
Format Patent
LanguageEnglish
Published 23.07.2020
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Bibliography:Application Number: US201916557819